Vietnam Pharmaceutical Market Outlook To 2022 - by Generic and Patented drugs, by Prescribed Drugs and OTC Drugs and Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory)

About the Report

About the Report

The report titled "Vietnam Pharmaceutical Market Outlook To 2022 - by Generic and Patented Drugs, by Prescribed Drugs and OTC Drugs and Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory)" provides a comprehensive analysis of Vietnam pharmaceutical market overview and size, growth drivers and restraints. The report also provides data points on Vietnam Pharmaceutical market by Generic and Patented Drugs, by Prescribed Drugs and OTC Drugs and Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory and Others) along with company profiles of DHG Pharma, Traphaco, Pymepharco, Ha Tey Pharmaceutical, Mekophar, Domesco, Imexpharma, OPC, Sanofi, GSK, AstraZeneca, Novartis, Roche, Pfizer, MSD and Bayer. The report also covers government regulations, the procedure of how drugs procured in public hospitals, Comparative Analysis of Pharmaceutical Companies, Trade scenario, Analyst Recommendations and future outlook for Vietnam Pharmaceutical Market.
Vietnam Pharmaceutical Market Research
Vietnam Pharmaceutical Market Size and Overview
The pharmaceutical market recorded growth at a CAGR of ~% during 2012-2017 increasing from USD ~ billion in 2012 to USD ~ billion in 2017, driven by a rise in self-medicating culture and OTC drug sales. Foreign entities are not allowed to engage in distribution activities; hence, they typically conduct marketing activities through representative offices or local drug distributors. The heightened regulatory environment for drug manufacturing has enabled entities that comply with regulatory standards to remain competitive.
Market Segmentation
By Generic and Patented Drugs: Generic drugs dominated the pharmaceutical market with a higher revenue share of ~% in 2017. Most common generic drugs sold in the market include antibiotics and pain killers. Patented drugs followed the generic drugs segment and generated a ~% revenue share in 2017. Currently, all patented drugs are imported for local consumption. Widely imported patented drugs include high-value specialty drugs for oncology and diabetes management.
By Prescribed Drugs and OTC Drugs: Prescribed drugs dominated the pharmaceutical market with a higher revenue share of ~% in 2017. Drugs prescribed by clinicians mostly consisted of imported and patented drugs. OTC drugs followed the prescribed drugs segment and generated a ~% revenue share in 2017. Sales of OTC drugs have been on an incline owing to a rise in the trend of self-medication in Vietnam. About 88-91% of antibiotics are sold via the OTC channel.
By Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory and Others): Metabolism and Nutritional Medicine dominated the therapeutic drugs in pharmaceutical market with the highest revenue share of ~% in the in 2017. The pharmaceutical market has witnessed high demand for nutritional and metabolism health supplements especially for segments including skincare, anti-aging, eye health, and digestive health. Antibiotic consumption has risen steeply in the last few years. Recent statistics reveal that about ~% to ~% of all antibiotics were sold without prescription in Vietnam. Others include contraception, gastrointestinal, skin, allergy, endocrine, analgesic and contributed ~% revenue share in the therapeutic drugs in the pharmaceutical market.
Future Outlook to Vietnam Pharmaceutical Market
The pharmaceutical market is expected to record growth at a CAGR of ~% during 2017-2022, driven by a rise in the utilization of generic drugs, especially those manufactured locally. Generic drug usage will continue to rise in the future owing to a rising number of drug manufacturers and the government’s push for production and utilization of locally produced. Prescribed drugs will dominate the pharmaceutical market but there will be an increase in the OTC medication due to self-medication. Antibiotics, Vitamins and dietary supplements will continue to attract heavy demand through the OTC channel. Demand for oncology drugs and system infections medicine is expected to become almost ~ times the size in 2017 with a revenue contribution of USD ~ million and USD ~ million in 2022. Respiratory drugs are anticipated to register the highest CAGR of ~% to reach USD ~ million by 2022.
Key Topics Covered in the Report
  • Vietnam Pharmaceutical Market Overview and Size
  • Vietnam Pharmaceutical Market Growth drivers
  • Vietnam Pharmaceutical Market Restraints
  • Vietnam Pharmaceutical Market by Generic and Patented drugs
  • Vietnam Pharmaceutical Market by Prescribed Drugs and OTC Drugs
  • Vietnam Pharmaceutical Market by Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory and Others)
  • Government regulations
  • The procedure of how drugs procured in public hospitals
  • Comparative Analysis of Pharmaceutical Companies
  • Trade scenario (Import and Export)
  • Analyst Recommendations for Vietnam Pharmaceutical Market
  • The future outlook for Vietnam Pharmaceutical Market

Products

Products

Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory, Generic, Patented drugs, Prescribed Drugs, OTC Drugs, Medicine Consumed, Medicine Imported


Companies

DHG Pharma, Traphaco, Pymepharco, Ha Tey Pharmaceutical, Mekophar, Domesco, Imexpharma, OPC, Sanofi, GSK, AstraZeneca, Novartis, Roche, Pfizer, MSD and Bayer

Table of Contents

Table of Contents

1. Research Methodology
1.1: Market Definitions
1.2: Abbreviations
1.3: Consolidated Research Approach
1.4: Market Sizing and Limitations
1.5: Products and Test Covered
1.6: Variables (Dependent and Independent)
1.7: Correlation Matrix
1.8: Regression Matrix
Healthcare Scenario
2.1: Healthcare Ecosystem
2.2: How are Healthcare Organizations Positioned
2.3: Vietnam Healthcare Metrics
2.4: Health Statistics
2.5: Vietnam Universal Health Coverage
Vietnam Healthcare Market
3.1: Vietnam Healthcare Market Size by Revenues
3.2: Vietnam Healthcare Market Segmentation by Healthcare Sectors, 2012 & 2017
3.3: Vietnam Healthcare Market Future Outlook and Projections, 2018-2022
Vietnam Pharmaceuticals Market
4.1: Executive Summary
4.2: Vietnam Pharmaceuticals Market Overview
4.3: Vietnam Pharmaceuticals Market Size by Revenues, 2012-2017
4.4: Growth Drivers in Vietnam Pharmaceuticals Market
4.5: Restraints in Vietnam Pharmaceuticals Market
4.6: Market Segmentation for Vietnam Pharmaceuticals Market by Generic and Patented Drugs, 2013 and 2017
4.7: Market Segmentation for Vietnam Pharmaceuticals Market by Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory), 2013 and 2017
4.8: Government Regulations for The Launch of New Drugs
4.9: How are Drugs Procured by Public Hospitals?
Comparative Analysis of Major Pharmaceutical Companies in Vietnam
4.10: Trade Scenario of Pharmaceutical Market in Vietnam (Imports and Exports), 2012-2017 4.11: Vietnam Pharmaceuticals Market Future Outlook and Projections, 2018-2022
4.12: Analyst Recommendations
Disclaimer

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022